Diabetes 54:2261-2265, 2005
© 2005 by the American Diabetes Association, Inc.
Evidence of an Association Between the Arg72 Allele of the Peptide YY and Increased Risk of Type 2 Diabetes
Signe S. Torekov1,2,
Lesli H. Larsen1,3,
Charlotte Glümer1,4,
Knut Borch-Johnsen1,4,5,
Torben Jørgensen4,
Jens J. Holst6,
Ole D. Madsen1,2,
Torben Hansen1, and
Oluf Pedersen1,5
1 Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
2 Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark
3 Danish Epidemiology Science Centre and Research Unit for Dietary Studies at the Institute of Preventive Medicine, Copenhagen University Hospital, Copenhagen, Denmark
4 Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark
5 Faculty of Health Science, University of Aarhus, Aarhus, Denmark
6 Department of Medical Physiology, University of Copenhagen, Denmark
We tested the hypothesis that variants in the gene encoding the prepropeptide YY (PYY) associate with type 2 diabetes and/or obesity. Mutation analyses of DNA from 84 patients with obesity and familial type 2 diabetes identified two polymorphisms, IVS3 + 68C>T and Arg72Thr, and one rare variant, +151C>A of PYY. The common allele of the Arg72Thr variant associated with type 2 diabetes with an allele frequency of the Arg allele of 0.667 (95% CI 0.658–0.677) among 4,639 glucose-tolerant subjects and 0.692 (0.674–0.710) among 1,326 patients with type 2 diabetes (P = 0.005, odds ratio 1.19 [95% CI 1.05–1.35]). The same polymorphism associated with overweight (25 BMI < 30 kg/m2) (P = 0.018, 1.15 [1.02–1.28]). In quantitative trait analyses of a population-based sample of 6,022 subjects, the Arg allele was associated with an increased plasma glucose level 2 h after an oral glucose tolerance test (OGTT) (P = 0.03), an increased area under the curve for the post-OGTT plasma glucose level (P = 0.03), and a lower insulinogenic index (P = 0.01). In conclusion, the common Arg allele of the PYY Arg72Thr variant modestly associates with type 2 diabetes and with type 2 diabetes–related quantitative traits.
Address correspondence and reprint requests to Signe S. Torekov, MSc, Steno Diabetes Center, Niels Steensens Vej 2, DK-2820, Gentofte, Denmark. E-mail: skto{at}steno.dk
Abbreviations:
HPLC, high-performance liquid chromatography; OGTT, oral glucose tolerance test; NPY, neuropeptide Y; PYY, peptide YY; UTR, untranslated region

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. D. Campbell, H. N. Lyon, J. Nemesh, J. A. Drake, T. Tuomi, D. Gaudet, X. Zhu, R. S. Cooper, K. G. Ardlie, L. C. Groop, et al.
Association Studies of BMI and Type 2 Diabetes in the Neuropeptide Y Pathway: A Possible Role for NPY2R as a Candidate Gene for Type 2 Diabetes in Men
Diabetes,
May 1, 2007;
56(5):
1460 - 1467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. le Roux, R. L. Batterham, S. J. B. Aylwin, M. Patterson, C. M. Borg, K. J. Wynne, A. Kent, R. P. Vincent, J. Gardiner, M. A. Ghatei, et al.
Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety
Endocrinology,
January 1, 2006;
147(1):
3 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|